№ lp_1_2_23036
File format: docx
Character count: 17369
File size: 218 KB
This document outlines strategies for optimizing the purchasing of pharmaceuticals in 340B hospitals to comply with the GPO Prohibition by assessing and managing WAC account, GPO, and 340B purchases.
Year:
2026
Region / City:
United States
Theme:
Healthcare, Pharmaceutical Purchasing
Document Type:
Guidelines
Organization:
340B Program
Author:
Not specified
Target Audience:
Covered entities in 340B hospitals
Validity Period:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Region / City:
Massachusetts, USA
Document Type:
User Guide / Contract Overview
Organization:
Operational Services Division (OSD), Commonwealth of Massachusetts
Contract Number:
MED57
Contract Term:
July 1, 2023–June 30, 2029 (option to extend to June 30, 2033)
Category Manager Contacts:
Sonia Castro, Tina Sang
Vendor:
Managed Healthcare Associates (MHA)
Intended Users:
State agencies, public institutions, non-profits, and other eligible entities
Update History:
12/17/25 updated Vendor Contact Information
Template Version:
9.0
Platform Reference:
COMMBUYS e-procurement system
Geographical Service Area:
Statewide Massachusetts
Year:
2023
Region / City:
United States
Topic:
Medicaid, 340B Program
Document Type:
Instructional Form
Organization:
HRSA (Health Resources and Services Administration)
Author:
HRSA
Target Audience:
Covered entities, contract pharmacies, Medicaid providers
Effective Period:
Ongoing
Approval Date:
March 5, 2010
Modification Date:
December 12, 2014
Year:
2025
Region / City:
United States
Topic:
340B Program Financial Impact
Document Type:
Tool / Guide
Organization / Institution:
Apexus
Author:
Apexus
Target Audience:
340B Covered Entities, Medicaid Agencies
Period of Validity:
2025
Approval Date:
2025
Modification Date:
Not specified
Year:
2024
Region / City:
United States
Subject:
340B Contract Pharmacy Policy Changes
Document Type:
Internal Memo
Organization:
Bausch Health
Author:
Bausch Health
Target Audience:
Internal employees of Bausch Health
Effective Date:
June 6, 2024
Amendment Date:
June 20, 2024
Start Date of Policy Change:
June 6, 2024
End Date of Policy Change:
October 1, 2025
Background:
In 1996, HHS issued guidance on 340B contract pharmacies.
Context:
This document provides detailed updates on Bausch Health’s evolving 340B contract pharmacy policies.
Year:
2021
Region / City:
Rockville, MD
Topic:
340B Drug Pricing Program
Document Type:
Guidance
Organization / Institution:
Health Resources and Services Administration (HRSA)
Author:
Apexus
Target Audience:
340B stakeholders, covered entities, health departments
Effective Period:
Ongoing
Approval Date:
2021
Date of Changes:
N/A
Year:
2025
Region / City:
Not specified
Topic:
340B Compliance Audit
Document Type:
Instructional Guide
Organization / Institution:
Apexus LLC
Author:
Not specified
Target Audience:
Covered Entity Leaders
Period of Action:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Note:
Year
Theme:
Pharmaceutical industry
Document type:
Manufacturer communication
Organization / institution:
[Manufacturer]
Author:
[Manufacturer]
Target audience:
Covered entities, stakeholders in the 340B program
Year:
2024
Program:
340B Drug Pricing Program
Subject:
Compliance policy and self-disclosure procedures
Document Type:
Guidance framework
Issuing Organization:
Apexus
Related Authority:
Health Resources and Services Administration (HRSA)
Intended Audience:
340B covered entity leaders and stakeholders
Scope:
Definition of material breach and self-disclosure to HRSA and manufacturers
Key Components:
Threshold indicators, policy criteria, sample statement, review procedures
Compliance Focus:
Diversion and duplicate discounts
Copyright:
© 2024 Apexus
Usage Rights:
Permitted for use, copying, and distribution by 340B covered entities and Medicaid agencies
Year:
2023
Region / City:
United States
Topic:
340B Program, Children’s Hospitals, Healthcare
Document Type:
Registration Form
Organization / Institution:
Office of Pharmacy Affairs (OPA)
Author:
Not specified
Target Audience:
Healthcare Providers, Children’s Hospitals
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2025
Region / City:
Washington State
Subject:
Electrical Inspection Fees
Document Type:
Fee Schedule
Organization:
Washington State Department of Labor & Industries
Author:
Washington State Department of Labor & Industries
Target Audience:
Electrical inspectors, field services staff, customers
Period of Validity:
Effective from July 1, 2025
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Year
Context:
A fill-in-the-blank template for a confined space entry program, detailing roles, responsibilities, and procedures for safe work in confined spaces, including hazard evaluation and employee training requirements.
Note:
Year
Topic:
Lead Abatement, Safety Procedures
Document Type:
Work Plan
Agency / Organization:
Environmental Health and Safety Office
Target Audience:
Contractors, Workers, Safety Supervisors
Work Description:
Lead hazard control measures, including abatement, encapsulation, and removal.
Project Location:
Site with known lead hazards
Control Measures:
HEPA vacuums, wet methods, protective clothing, respirators, etc.
Equipment and Materials:
HEPA vacuums, protective clothing, respirators, and other abatement tools
Crew:
Lead abatement supervisor and a crew of workers
Competent Person:
Lead abatement supervisor (certified)
Technology Considered:
HUD Guidelines for lead hazard control, specialized equipment for lead abatement
Respirators:
NIOSH/MSHA approved respirators provided to workers
Protective Clothing:
Disposable, breathable fabric clothing worn at all times
Hygiene Facilities:
Hand washing and decontamination facilities provided on-site
Air Monitoring Data:
Air sampling to be conducted for lead monitoring
Agency:
Washington State Noxious Weed Control Board
Hearing Date:
March 11th, 2025
Intended Adoption Date:
March 12th, 2025
Proponent:
Washington State Noxious Weed Control Board
Purpose:
Update of State Noxious Weed List, including addition of English holly, Ilex aquifolium, as a Class C noxious weed
Jurisdiction:
Washington State
Governing Body:
Washington State Board of Nursing (WABON)
Legal Basis:
WAC 246-840-513
Related Legislation:
RCW 42.56 (Public Records Act)
Document Type:
Official Incident Report Form
Purpose:
Reporting incidents involving students or faculty resulting in patient harm, unreasonable risk of harm, or diversion of legend drugs or controlled substances
Responsible Unit:
WABON Education Unit
Submission Method:
Email submission to [email protected]
Data Use:
Collection and possible publication of unidentifiable aggregate data
Year:
2017
Region / City:
FAU (Florida Atlantic University)
Topic:
WAC Program, Committee Updates, Syllabi, Assessment, Curriculum
Document Type:
Meeting Minutes
Organization / Institution:
FAU WAC Committee
Author:
WAC Committee Members
Target Audience:
Faculty, Staff, Committee Members
Action Period:
2017-2018
Approval Date:
April 17, 2017
Modification Date:
N/A
Contextual description:
Meeting minutes detailing discussions and updates regarding the WAC program, committee members, syllabi re-certification, and assessment interface at FAU.
Year:
2015
Region / City:
Not specified
Subject:
WAC courses and committee discussions
Document Type:
Meeting Agenda
Institution:
Not specified
Author:
Not specified
Target Audience:
WAC committee members, faculty involved in WAC courses
Period of Action:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2024
Region:
Washington State, USA
Subject:
Adoption of rules related to account distribution and domestic relations orders
Type of document:
Government notice
Governing body:
Washington State Department of Retirement Systems
Author:
Bianca Stoner
Target audience:
Account beneficiaries and interested parties
Effective period:
Upon adoption
Hearing date:
September 26, 2024
Rule citations:
WSR 24-17-060; Amended WAC Sections 415-501-488, 415-501-491, 415-501-495
Reason for adoption:
Implementation of SECURE Act 2022 provisions and alignment with other DCP WACs
Summary of comments:
None
Differences in text:
None
Year:
2025
Region / City:
Washington State, USA
Topic:
Administrative rule adoption
Document Type:
Official notice
Governing Body / Institution:
Washington State Department of Retirement Systems
Author:
Bianca Stoner
Target Audience:
Interested parties and members of LEOFF
Effective Period:
Upon adoption
Hearing Date:
June 2, 2025
Adoption Date:
June 30, 2025
Related Legislation:
Chapter 304, Laws of 2024, Part II
Rule Section Amended:
WAC 415-104-225
Year:
2010
Region:
Washington State, USA
Subject:
Health care coverage, Pharmacist services
Document type:
Formal complaint letter
Author:
Donald F. Downing, Licensed Pharmacist
Target audience:
Washington State Insurance Commissioner, Health plan regulators
Legal references:
RCW 48.43.045, WAC 284-43-205, RCW 48.43.005(4), RCW 18-64.011(11), WAC 246-863-100, WAC 246-864-110
Period covered:
1995–2010
Key issue:
Non-compliance of Regence BlueShield with state law regarding coverage of pharmacist-provided clinical services
Supporting evidence:
Example of provider enrollment rejection dated April 22, 2010
Year:
2022
Region / State:
Colorado, USA
Subject:
Prescription drug pricing and information
Document type:
Regulatory information notice
Legislation:
Colorado House Bill 19-1131
Drug:
ALVESCO (ciclesonide) Inhalation Aerosol
Dosage forms:
80 MCG/ACT, 160 MCG/ACT
Price type:
Wholesaler Acquisition Cost (WAC)
Comparison:
Generic drugs in the same therapeutic class
Target audience:
Colorado prescribers
Effective date:
July 1, 2022